World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
116
Citations
76832
World Ranking
4263
National Ranking
2331

Overview

Samuel Singer is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research spans primarily the field of Medicine, with a focused contribution to several subfields including Pulmonary and Respiratory Medicine, Oncology, Rheumatology, Molecular Biology, and Cancer Research.

The scientist's work addresses key topics such as Sarcoma Diagnosis and Treatment, Vascular Tumors and Angiosarcomas, CAR-T cell therapy research, Glioma Diagnosis and Treatment, Gastrointestinal Tumor Research and Treatment, Cancer Genomics and Diagnostics, and Cancer Immunotherapy and Biomarkers.

Among their recent published papers are:

  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients, 2022, Cell
  • Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets, 2022, Nature Communications
  • Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma, 2022, Nature Communications
  • Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor, 2023, Journal of Clinical Oncology
  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients, 2021, bioRxiv (Cold Spring Harbor Laboratory)

Frequent coauthors collaborating with Samuel Singer include William D. Tap, Ping Chi, Cristina R. Antonescu, Sandra P. D'Angelo, and Mrinal M. Gounder.

The most common venues for Samuel Singer's publications are:

  • Journal of Clinical Oncology
  • Clinical Cancer Research
  • Modern Pathology
  • Annals of Surgical Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)

Best Publications

  • Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.

    George Daniel Demetri;Margaret von Mehren;Charles D. Blanke;Annick Diane Van Den Abbeele

  • The landscape of somatic copy-number alteration across human cancers

    Rameen Beroukhim;Craig H. Mermel;Craig H. Mermel;Dale Porter;Guo Wei

  • Oncogenic Signaling Pathways in The Cancer Genome Atlas

    Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors

    Michael C. Heinrich;Christopher L. Corless;Anette Duensing;Laura McGreevey

  • Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor

    Michael C. Heinrich;Christopher L. Corless;George D. Demetri;Charles D. Blanke

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Comprehensive Characterization of Cancer Driver Genes and Mutations.

    Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • Differentiation and reversal of malignant changes in colon cancer through PPARgamma.

    Pasha Sarraf;Elisabetta Mueller;Daniel Jones;Frederick J. King

  • KIT activation is a ubiquitous feature of gastrointestinal stromal tumors.

    Brian P. Rubin;Samuel Singer;Connie Tsao;Anette Duensing

  • Terminal Differentiation of Human Breast Cancer through PPARγ

    Elisabetta Mueller;Pasha Sarraf;Peter Tontonoz;Peter Tontonoz;Ronald M. Evans;Ronald M. Evans

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

  • Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas

    Adam Abeshouse;Clement Adebamowo;Sally N. Adebamowo;Rehan Akbani

  • Acquired Resistance to Imatinib in Gastrointestinal Stromal Tumor Occurs Through Secondary Gene Mutation

    Cristina R. Antonescu;Peter Besmer;Tianhua Guo;Knarik Arkun

  • STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications

    David A. Tuveson;Nicholas A. Willis;Tyler Jacks;Tyler Jacks;James D. Griffin

  • Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte–macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

    R Soiffer;T Lynch;M Mihm;K Jung

  • Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptor

    Peter Tontonoz;Samuel Singer;Barry M. Forman;Pasha Sarraf

  • MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: a feasibility study.

    Kullervo Hynynen;Oliver Pomeroy;Darrell N. Smith;Peter E. Huber

  • KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors.

    Marcia L. Lux;Brian P. Rubin;Tara L. Biase;Chang Jie Chen

  • Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing

    Dan R. Robinson;Yi Mi Wu;Shanker Kalyana-Sundaram;Shanker Kalyana-Sundaram;Xuhong Cao

Frequent Co-Authors

Cristina R. Antonescu
Cristina R. Antonescu Memorial Sloan Kettering Cancer Center
Murray F. Brennan
Murray F. Brennan Memorial Sloan Kettering Cancer Center
Robert G. Maki
Robert G. Maki University of Pennsylvania
Christopher D.M. Fletcher
Christopher D.M. Fletcher Brigham and Women's Hospital
Gary K. Schwartz
Gary K. Schwartz Memorial Sloan Kettering Cancer Center
Nicholas D. Socci
Nicholas D. Socci Memorial Sloan Kettering Cancer Center
George D. Demetri
George D. Demetri Dana-Farber Cancer Institute
Marc Ladanyi
Marc Ladanyi Memorial Sloan Kettering Cancer Center
Jonathan A. Fletcher
Jonathan A. Fletcher Brigham and Women's Hospital
Ronald P. DeMatteo
Ronald P. DeMatteo University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn't always require following a traditional pathway. Many students are now turning to flexible online programs that allow them to balance education with work and personal commitments. For registered nurses, rn bsn online programs no clinicals offer the opportunity to upskill without mandatory hands-on clinical components, making them ideal for working professionals.

If advancing in nursing is your goal, you might consider the quickest dnp program or dnp programs without dissertation. These innovative tracks are designed to streamline the pathway to a Doctor of Nursing Practice, removing barriers such as lengthy capstone projects or dissertations.

For those looking to enter the healthcare workforce quickly, a 6 month lpn program enables rapid entry into practical nursing. These programs are structured for speed while still preparing graduates for immediate employment. With so many flexible options, it's easier than ever to start or advance your healthcare career online.

Best Scientists Citing Samuel Singer

Trending Scientists

Recently Published Articles